Title {1}	Impact of Rapid Molecular Testing on Diagnosis, Treatment and Management of Community Acquired Pneumonia in Norway: a pragmatic randomised controlled trial (CAPNOR)
Trial registration {2a and 2b}.	ClinicalTrials.gov: identifier number: NCT04660084 A pdf-file with the World Health Organization Trial Registration Data Set is shown in “Additional file 1”.
Protocol version {3}	Version 3, 21st August 2020
Funding {4}	The Research Council of Norway (NORCAP; 288718) is the primary funder of the trial. Additional funding support is obtained from the Trond Mohn Foundation, the University of Bergen (UiB), and Haukeland University Hospital (HUH).
Author details {5a}	Sondre Serigstad1,2, Christian Ritz3,4,*, Daniel Faurholt-Jepsen5, Dagfinn Markussen1, Marit H. Ebbesen6, Øyvind Kommedal3,6, Rune O. Bjørneklett1,2, Lars Heggelund3,7, Tristan W. Clark8, Cornelis H. van Werkhoven9, Siri T. Knoop6, Elling Ulvestad3,6, Harleen M.S. Grewal3,6,*, and the CAPNOR study group *joint corresponding authors 1 Emergency Care Clinic, Haukeland University Hospital, Bergen, Norway 2 Department of Clinical Medicine, Faculty of Medicine, University of Bergen, Bergen, Norway 3 Department of Clinical Science, Bergen Integrated Diagnostic Stewardship cluster, Faculty of Medicine, University of Bergen, Bergen, Norway 4 National Institute of Public Health, University of Southern Denmark, Copenhagen, Denmark 5 Department of Infectious Diseases, Rigshospitalet, Copenhagen, Denmark. 6 Department of Microbiology, Haukeland University Hospital, Bergen, Norway 7 Department of Internal Medicine, Vestre Viken Hospital Trust, Drammen, Norway. 8 School of Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, UK 9 Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands.
Name and contact information for the trial sponsor {5b}	University of Bergen Contact information: University of Bergen ​Jonas Lies veg 87 N-5021 Bergen
Role of sponsor {5c}	The sponsor and funders had no role in the study design, and they will have no role in the collection, management, analysis, and interpretation of data nor in the decision to submit the report for publication.